US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

ERISA Recap: 5 Litigation Developments From April No Photo Available

Kellie Mejdrich

The U.S. Supreme Court turned down a bakery company's bid for review of a union multiemployer pension withdrawal bill, the Fourth Circ... (more story)

This Week's Healthcare Earnings: Eli Lilly, Cigna And More No Photo Available

Yeji Jesse Lee

A smattering of drugmakers and payors posted their first-quarter results this past week, with largely positive readouts of the start of the year.

Calif. Justices To Weigh Gilead Negligence Claim In HIV Suit No Photo Available

Mark Payne

A case before the California Supreme Court this week involving Gilead and HIV medications may create a new standard for negligence cla... (more story)